SRD5A2基因新型复合杂合突变致类固醇5-&alpha;还原酶2型缺乏症的遗传变异分析

初国铭; 李萍萍; 常文婧; 何蓉; 赵彦艳

doi:10.7499/j.issn.1008-8830.1912041

PDF(2479 KB)

HTML

中国当代儿科杂志 ›› 2020, Vol. 22 ›› Issue (7) : 790-795. DOI: 10.7499/j.issn.1008-8830.1912041

罕见病研究

SRD5A2基因新型复合杂合突变致类固醇5-α还原酶2型缺乏症的遗传变异分析

初国铭¹, 李萍萍², 常文婧¹, 何蓉¹, 赵彦艳¹

作者信息 +

Variant analysis on steroid 5-reductase type 2 deficiency caused by a novel SRD5A2 mutation

CHU Guo-Ming¹, LI Ping-Ping², CHANG Wen-Jing¹, HE Rong¹, ZHAO Yan-Yan¹

Author information +

文章历史 +

摘要

该文报道1例类固醇5-α还原酶2型缺乏症患儿的临床特征及SRD5A2基因突变特点。患儿男性，2月龄，生后即出现尿道下裂及阴茎短小。提取患儿及父母外周血DNA，通过高通量测序技术对患儿DNA样本进行内分泌疾病相关基因的捕获测序，并对家系DNA样本进行Sanger测序验证。结果显示患儿SRD5A2基因存在c.680G > A（p.R227Q）和c.608G > A（p.G203D）复合杂合突变，其中c.680G > A来源于其父亲，为已知致病性突变，c.608G > A来源于其母亲，为新发现的突变。该研究为患儿病因诊断及该家系的遗传咨询提供了分子依据，并扩展了SRD5A2基因突变谱。

Abstract

This article reported the clinical characteristics and SRD5A2 gene mutation pattern of a child with steroid 5-α reductase type 2 deficiency. The 2-month-old boy showed hypospadias and short penis shortly after birth. DNA was extracted from the peripheral blood of the child and his parents. The endocrine disease-related genes were captured and sequenced by high-throughput sequencing technology, and the family DNA samples were verified by Sanger sequencing. The results showed that c.680G > A(p.R227Q) and c.608G > A(p.G203D) compound heterozygous mutations existed in the SRD5A2 gene of the child. The c.680G > A mutation inherited from his father, which was a known pathogenic mutation. The c.608G > A mutation originated from his mother, which was a novel mutation discovered in this study. These results provide molecular evidence for the etiological diagnosis of the child and genetic counseling for the family, as well as extend the mutation spectrum of SRD5A2 gene.

导出引用

初国铭, 李萍萍, 常文婧, 何蓉, 赵彦艳. SRD5A2基因新型复合杂合突变致类固醇5-α还原酶2型缺乏症的遗传变异分析[J]. 中国当代儿科杂志. 2020, 22(7): 790-795 https://doi.org/10.7499/j.issn.1008-8830.1912041

CHU Guo-Ming, LI Ping-Ping, CHANG Wen-Jing, HE Rong, ZHAO Yan-Yan. Variant analysis on steroid 5-reductase type 2 deficiency caused by a novel SRD5A2 mutation[J]. Chinese Journal of Contemporary Pediatrics. 2020, 22(7): 790-795 https://doi.org/10.7499/j.issn.1008-8830.1912041

参考文献

[1] Wang T, Liu JH, Yang J, et al. 46,XX male sex reversal syndrome:a case report and review of the genetic basis[J]. Andrologia, 2009, 41(1):59-62.
[2] Berglund A, Johannsen TH, Stochholm K, et al. Incidence, prevalence, diagnostic delay, and clinical presentation of female 46,XY disorders of sex development[J]. J Clin Endocrinol Metab, 2016, 101(12):4532-4540.
[3] Tajima T, Fujieda K, Kouda N, et al. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency[J]. J Clin Endocrinol Metab, 2001, 86(8):3820-3825.
[4] Miller WL. Mechanisms in endocrinology:rare defects in adrenal steroidogenesis[J]. Eur J Endocrinol, 2018, 179(3):R125-R141.
[5] Ye L, Su ZJ, Ge RS. Inhibitors of testosterone biosynthetic and metabolic activation enzymes[J]. Molecules, 2011, 16(12):9983-10001.
[6] Lund L, Engebjerg MC, Pedersen L, et al. Prevalence of hypospadias in Danish boys:a longitudinal study, 1977-2005[J]. Eur Urol, 2009, 55(5):1022-1026.
[7] Thareja S. Steroidal 5α-reductase inhibitors:a comparative 3D-QSAR study review[J]. Chem Rev, 2015, 115(8):2883-2894.
[8] Walsh PC, Madden JD, Harrod MJ, et al. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias[J]. N Engl J Med, 1974, 291(18):944-949.
[9] Andersson S, Berman DM, Jenkins EP, et al. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism[J]. Nature, 1991, 354(6349):159-161.
[10] Nagaraja MR, Gubbala SP, Delphine Silvia CRW, et al. Molecular diagnostics of disorders of sexual development:an Indian survey and systems biology perspective[J]. Syst Biol Reprod Med, 2019, 65(2):105-120.
[11] Hiort O, Sinnecker GH, Willenbring H, et al. Nonisotopic single Strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency[J]. J Clin Endocrinol Metab, 1996, 81(9):3415-3418.
[12] Gui B, Song Y, Su Z, et al. New insights into 5α-reductase type 2 deficiency based on a multi-centre study:regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients[J]. J Med Genet, 2019, 56(10):685-692.
[13] Vilchis F, Ramos L, Méndez JP, et al. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization:the P212R substitution of the steroid 5alpha-reductase 2 may constitute an ancestral founder mutation in Mexican patients[J]. J Androl, 2010, 31(4):358-364.
[14] Avendaño A, Paradisi I, Cammarata-Scalisi F, et al. 5-α-Reductase type 2 deficiency:is there a genotype-phenotype correlation? A review[J]. Hormones (Athens), 2018, 17(2):197-204.
[15] Cheng J, Lin R, Zhang W, et al. Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China[J]. Clin Endocrinol (Oxf), 2015, 83(4):518-526.
[16] Mazen I, Gad YZ, Hafez M, et al. Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated Egyptian children with suspected 5alpha-reductase deficiency:prevalence of the G34R mutation[J]. Clin Endocrinol (Oxf), 2003, 58(5):627-631.
[17] Leme de Calais FL, Soardi FC, Petroli RJ, et al. Molecular diagnosis of 5α-reductase type II deficiency in Brazilian siblings with 46,XY disorder of sex development[J]. Int J Mol Sci, 2011, 12(12):9471-9480.
[18] Cai LQ, Zhu YS, Katz MD, et al. 5 alpha-reductase-2 gene mutations in the Dominican Republic[J]. J Clin Endocrinol Metab, 1996, 81(5):1730-1735.
[19] Yang Y, Wang BA, Guo QH, et al. Clinical and genetic analysis of three Chinese patients with steroid 5α-reductase type 2 deficiency[J]. J Pediatr Endocrinol Metab, 2012, 25(11-12):1077-1082.
[20] Kilcoyne KR, Mitchell RT. Effect of environmental and pharmaceutical exposures on fetal testis development and function:a systematic review of human experimental data[J]. Hum Reprod Update, 2019, 25(4):397-421.